Brian Walitt: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
Doctor '''Brian Walitt''' is a pain researcher at the [[National Institutes of Health]] (NIH) in the United States and oversees intramural clinical protocols. | Doctor '''Brian Walitt''' is a pain researcher at the [[National Institutes of Health]] (NIH) in the United States and oversees intramural clinical protocols. He is the lead clinical investigator of the [[NIH Post-Infectious ME/CFS Study]]. | ||
==Research== | ==Research== |
Revision as of 03:19, February 21, 2016
Doctor Brian Walitt is a pain researcher at the National Institutes of Health (NIH) in the United States and oversees intramural clinical protocols. He is the lead clinical investigator of the NIH Post-Infectious ME/CFS Study.
Research[edit | edit source]
Dr. Walitt's self-stated research interests include "Pain and related interoceptive disorders (i.e. fibromyalgia, chronic fatigue)" and "Social construction of illness and disease."
Controversy[edit | edit source]
Walitt believes that Fibromyalgia is a psychosomatic experience, a variant of normal, and not an abnormal disease state that should be medicalized.[1] In a 2015 paper on chemotherapy related cognitive dysfunction[2] co-authored by Walitt, Fibromyalgia and Chronic Fatigue Syndrome are referred to as somatoform illnesses, with their hallmark being a "...discordance between the severity of subjective experience and that of objective impairment...".